Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-22-053555
Filing Date
2022-04-29
Accepted
2022-04-29 16:10:42
Documents
4

Document Format Files

Seq Description Document Type Size
1 DEFA14A tm223560d2_defa14a.htm DEFA14A 9859
2 GRAPHIC tm223560d2_defa14aimg003.jpg GRAPHIC 150784
3 GRAPHIC tm223560d2_defa14aimg004.jpg GRAPHIC 96926
4 GRAPHIC tm223560d2_defa14aimg005.jpg GRAPHIC 4229
  Complete submission text file 0001104659-22-053555.txt   358204
Mailing Address 9000 VIRGINIA MANOR ROAD, SUITE 200 BELTSVILLE MD 20705
Business Address 9000 VIRGINIA MANOR ROAD, SUITE 200 BELTSVILLE MD 20705 240-399-4900
NextCure, Inc. (Filer) CIK: 0001661059 (see all company filings)

EIN.: 475231247 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38905 | Film No.: 22875409
SIC: 2834 Pharmaceutical Preparations